Literature DB >> 17719273

Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial.

Vic Hasselblad1, Wendy Gattis Stough, Monica R Shah, Yuliya Lokhnygina, Christopher M O'Connor, Robert M Califf, Kirkwood F Adams.   

Abstract

BACKGROUND: We examined the relation of maximal in-hospital diuretic dose to weight loss, changes in renal function, and mortality in hospitalised heart failure (HF) patients.
METHODS: In ESCAPE, 395 patients received diuretics in-hospital. Weight was measured at baseline, discharge, and every other day before discharge. Weight loss was defined as the difference between baseline and last in-hospital weight. Mortality was assessed using a log-logistic model with non-zero background.
RESULTS: Median weight loss: 2.8 kg (0.7, 6.1); mean: 3.7 kg (22% of values <0). Weight loss and maximum in-hospital dose were correlated (p=0.0007). Baseline weight, length of stay, and baseline brain natriuretic peptide were significant predictors of weight loss. After adjusting for these, dose was not a significant predictor of weight loss. A strong relation between dose and mortality was seen (p=0.003), especially at >300 mg/day. Dose remained a significant predictor of mortality after adjusting for baseline variables that significantly predicted mortality. Correlation between maximal dose and creatinine level change was not significant (r=0.043; p=0.412)
CONCLUSIONS: High diuretic doses during HF hospitalisation are associated with increased mortality and poor 6-month outcome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17719273      PMCID: PMC3127394          DOI: 10.1016/j.ejheart.2007.07.011

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  11 in total

1.  Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale.

Authors:  M R Shah; C M O'Connor; G Sopko; V Hasselblad; R M Califf; L W Stevenson
Journal:  Am Heart J       Date:  2001-04       Impact factor: 4.749

2.  The clinical challenge of cardiorenal syndrome.

Authors:  Michael G Shlipak; Barry M Massie
Journal:  Circulation       Date:  2004-09-21       Impact factor: 29.690

Review 3.  The severe cardiorenal syndrome: 'Guyton revisited'.

Authors:  Lennart G Bongartz; Maarten Jan Cramer; Pieter A Doevendans; Jaap A Joles; Branko Braam
Journal:  Eur Heart J       Date:  2004-11-30       Impact factor: 29.983

4.  Risk stratification after hospitalization for decompensated heart failure.

Authors:  G Michael Felker; Jeffrey D Leimberger; Robert M Califf; Michael S Cuffe; Barry M Massie; Kirkwood F Adams; Mihai Gheorghiade; Christopher M O'Connor
Journal:  J Card Fail       Date:  2004-12       Impact factor: 5.712

5.  Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema.

Authors:  G Cotter; E Metzkor; E Kaluski; Z Faigenberg; R Miller; A Simovitz; O Shaham; D Marghitay; M Koren; A Blatt; Y Moshkovitz; R Zaidenstein; A Golik
Journal:  Lancet       Date:  1998-02-07       Impact factor: 79.321

6.  Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction.

Authors:  H A Cooper; D L Dries; C E Davis; Y L Shen; M J Domanski
Journal:  Circulation       Date:  1999-09-21       Impact factor: 29.690

7.  Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis.

Authors:  Gregg C Fonarow; Kirkwood F Adams; William T Abraham; Clyde W Yancy; W John Boscardin
Journal:  JAMA       Date:  2005-02-02       Impact factor: 56.272

8.  Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.

Authors:  G Cotter; J Weissgarten; E Metzkor; Y Moshkovitz; I Litinski; U Tavori; C Perry; R Zaidenstein; A Golik
Journal:  Clin Pharmacol Ther       Date:  1997-08       Impact factor: 6.875

9.  Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.

Authors:  A J Scheen; J C Vancrombreucq; J Delarge; A S Luyckx
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Diuretic resistance predicts mortality in patients with advanced heart failure.

Authors:  Gerald W Neuberg; Alan B Miller; Chris M O'Connor; Robert N Belkin; Peter E Carson; Anne B Cropp; David J Frid; Regina G Nye; Milton L Pressler; John H Wertheimer; Milton Packer
Journal:  Am Heart J       Date:  2002-07       Impact factor: 4.749

View more
  107 in total

1.  Early changes in clinical characteristics after emergency department therapy for acute heart failure syndromes: identifying patients who do not respond to standard therapy.

Authors:  Sean P Collins; Christopher J Lindsell; Alan B Storrow; Gregory J Fermann; Phillip D Levy; Peter S Pang; Neal Weintraub; W Frank Peacock; Douglas B Sawyer; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 2.  A reappraisal of loop diuretic choice in heart failure patients.

Authors:  Jonathan Buggey; Robert J Mentz; Bertram Pitt; Eric L Eisenstein; Kevin J Anstrom; Eric J Velazquez; Christopher M O'Connor
Journal:  Am Heart J       Date:  2015-01-06       Impact factor: 4.749

Review 3.  Prognostic factors in patients hospitalized for heart failure.

Authors:  Lakshmi Sridharan; Liviu Klein
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 4.  New insights into combinational drug therapy to manage congestion in heart failure.

Authors:  Frederik Hendrik Verbrugge; Lars Grieten; Wilfried Mullens
Journal:  Curr Heart Fail Rep       Date:  2014-03

5.  Slope of the anterior mitral valve leaflet: a new measurement of left ventricular unloading for left ventricular assist devices and systolic dysfunction.

Authors:  Sara C Martinez; Elisa A Bradley; Eric L Novak; Ravi Rasalingam; Ari M Cedars; Gregory A Ewald; Scott C Silvestry; Susan M Joseph
Journal:  Tex Heart Inst J       Date:  2014-06-01

Review 6.  Treatment of congestion in heart failure with diuretics and extracorporeal therapies: effects on symptoms, renal function, and prognosis.

Authors:  Maria Rosa Costanzo; Mariell Jessup
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

Review 7.  Loop diuretics in heart failure.

Authors:  G Michael Felker
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

8.  Association between deteriorated renal function and long-term clinical outcomes after percutaneous coronary intervention.

Authors:  Manabu Ogita; Kenichi Sakakura; Tomohiro Nakamura; Hiroshi Funayama; Hiroshi Wada; Ryo Naito; Yoshitaka Sugawara; Norifumi Kubo; Junya Ako; Shin-ichi Momomura
Journal:  Heart Vessels       Date:  2011-08-06       Impact factor: 2.037

9.  Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study.

Authors:  Marco Metra; John R Teerlink; G Michael Felker; Barry H Greenberg; Gerasimos Filippatos; Piotr Ponikowski; Sam L Teichman; Elaine Unemori; Adriaan A Voors; Beth Davison Weatherley; Gad Cotter
Journal:  Eur J Heart Fail       Date:  2010-08-22       Impact factor: 15.534

10.  Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative.

Authors:  Claudio Ronco; Peter McCullough; Stefan D Anker; Inder Anand; Nadia Aspromonte; Sean M Bagshaw; Rinaldo Bellomo; Tomas Berl; Ilona Bobek; Dinna N Cruz; Luciano Daliento; Andrew Davenport; Mikko Haapio; Hans Hillege; Andrew A House; Nevin Katz; Alan Maisel; Sunil Mankad; Pierluigi Zanco; Alexandre Mebazaa; Alberto Palazzuoli; Federico Ronco; Andrew Shaw; Geoff Sheinfeld; Sachin Soni; Giorgio Vescovo; Nereo Zamperetti; Piotr Ponikowski
Journal:  Eur Heart J       Date:  2009-12-25       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.